Sally Church's Library tagged pharmaceuticals →  View Popular

Generic drugs are getting even cheaper - monthly prescriptions for hypertensives, breast cancer and other for under a fiver.

walmartstores.com/...8248.aspx - Preview

managed care reimbursement health pharmaceuticals Drugs

Market insights and intelligence on the world of blood based products and cancers

hematologymarketinsights.blogspot.com - Preview

hematology oncology biotechnology pharmaceuticals strategy treatment technology testing

As we learn more about how cancer work, so do the technologies for eradicating them become more sophisticated. Insights into the changing scientific world of cancer.

cancertechinsights.blogspot.com - Preview

technology insights oncology hematology cancer testing pharmaceuticals biotechnology

A new blog - developments in the science and biology of cancer disease

oncologymarkettrends.blogspot.com - Preview

biotechnology oncology cancer pharmaceuticals pharma strategy medicine marketing science

News and views from the cancer arena from Sally

oncologyconsultingnews.blogspot.com - Preview

oncology biotechnology cancer pharma pharmaceuticals marketing research consulting strategy news

Gammagard is being studied in Alzheimer’s disease, binds directly to multiple
aggregated, or clustered, forms of the beta-amyloid peptide molecule. The beta-amyloid
molecule may contribute to beta-amyloid plaques, which are thought to be the primary

www.baxter.com - Preview

alzheimers pharmaceuticals research biomarkers testing

Few Doctors have the time to write medical articles so the timing of the uproar with Merck-SP's Vytorin news is somewhat suspicious.

www.nytimes.com/...19ghost.html - Preview

business FDA FDAMA pharmaceuticals biotechnology strategy companies

This bill represents landmark legislation in the US, protecting patients who need genetic testing from being discriminated against by insurers or employers. A victory for common sense.

oncochat.typepad.com/oncochat - Preview

biotechnology pharmaceuticals managed care reimbursement patients Legislation genetics testing technology

The revenge of the US health care plans - pay MUCH more if you are ill - will this lead to a two-tier healthcare system based on ability to pay?

The cost of many drugs has increased from a $25-50 co-pay per month to 20-33% of the actual cost. This mea

www.nytimes.com/...14drug.html - Preview

biotechnology companies business economy pharmaceuticals strategy reimbursement treatment disease People

"Mutations in a gene called GIGYF2 may be directly linked to the development of Parkinson's disease in families with a history of the neurodegenerative condition..." if true, then this may be a useful target for future drug development in this devastating

health.yahoo.com/...toformofparkinsonsdisease.html - Preview

Parkinsons research innovation biomarkers pharmaceuticals

There is always much shaking of heads and wringing of hands when high profile drugs or technologies fail...

www.washingtonpost.com/...AR2008032003398.html - Preview

AIDS HIV vaccine research pharmaceuticals

New developments in understanding the biology may lead to a breakthrough in HIV treatment in the future!

oncochat.typepad.com/...hiv---the-moder.html - Preview

HIV innovation medicine biotechnology pharmaceuticals

These cases are always sad - there is no evidence that giving drugs to terminally ill cancer patients will cure them. Potentially prolong their life by a few days or weeks, but the end result is likely to be the same. Sometimes, allowing patients to die

news.yahoo.com/...scotus_experimental_drugs - Preview

approvals early oncology testing pharmaceuticals medicine People innovation

Consulting to pharmaceutical and biotechnology companies on marketing strategy and new product development

www.squidoo.com/icarusconsultants - Preview

strategy marketing consulting cancer oncology pharmaceuticals biotechnology